BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Luo C, Wang X, Mao X, Huang H, Liu Y, Zhao J, Zhou H, Liu Z, Li X. Metformin attenuates antipsychotic-induced metabolic dysfunctions in MK801-induced schizophrenia-like rats. Psychopharmacology 2020;237:2257-77. [DOI: 10.1007/s00213-020-05524-w] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
Number Citing Articles
1 Kanagali SN, Patil BM, Khanal P, Unger BS. Cyperus rotundus L. reverses the olanzapine-induced weight gain and metabolic changes-outcomes from network and experimental pharmacology. Comput Biol Med 2021;:105035. [PMID: 34802711 DOI: 10.1016/j.compbiomed.2021.105035] [Reference Citation Analysis]
2 Yu J, Liao X, Zhong Y, Wu Y, Lai X, Jiao H, Yan M, Zhang Y, Ma C, Wang S. The Candidate Schizophrenia Risk Gene Tmem108 Regulates Glucose Metabolism Homeostasis. Front Endocrinol (Lausanne) 2021;12:770145. [PMID: 34690937 DOI: 10.3389/fendo.2021.770145] [Reference Citation Analysis]
3 Sun ZY, Gu LH, Ma DL, Wang MY, Yang CC, Zhang L, Li XM, Zhang JW, Li L. Behavioral and neurobiological changes in a novel mouse model of schizophrenia induced by the combination of cuprizone and MK-801. Brain Res Bull 2021;174:141-52. [PMID: 34119597 DOI: 10.1016/j.brainresbull.2021.06.007] [Reference Citation Analysis]
4 Yuen JWY, Wu C, Wang CK, Kim DD, Procyshyn RM, Panenka WG, Honer WG, Barr AM. A ganglionic blocker and adrenoceptor ligands modify clozapine-induced insulin resistance. Psychoneuroendocrinology 2021;129:105257. [PMID: 34023734 DOI: 10.1016/j.psyneuen.2021.105257] [Reference Citation Analysis]
5 Luo C, Wang X, Huang HX, Mao XY, Zhou HH, Liu ZQ. Coadministration of metformin prevents olanzapine-induced metabolic dysfunction and regulates the gut-liver axis in rats. Psychopharmacology (Berl) 2021;238:239-48. [PMID: 33095288 DOI: 10.1007/s00213-020-05677-8] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
6 Chen Q, Cao T, Li N, Zeng C, Zhang S, Wu X, Zhang B, Cai H. Repurposing of Anti-Diabetic Agents as a New Opportunity to Alleviate Cognitive Impairment in Neurodegenerative and Neuropsychiatric Disorders. Front Pharmacol 2021;12:667874. [PMID: 34108878 DOI: 10.3389/fphar.2021.667874] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]